HEALTH

Nature’s Health Connection’s Australian Dream achieves record sales

BY Allison Cerra

REDFORD, Mich. — Nature’s Health Connection said its over-the-counter pain-relief cream has garnered record retail sales.

Sales for Australian Dream — a Food and Drug Administration-approved odorless, greaseless, dye-free and capsaicin-free cream — increased more than 145%, according to the company. Nature’s Health Connection attributed the sales spike to a 30-second television commercial. 

Australian Dream is designed to treat minor aches and pains associated with osteo- and rheumatoid arthritis, as well as other muscle ailments.

Australian Dream is available at select Walgreens locations and online at AustralianDream.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Hi-Tech Pharmacal acquires candidiasis treatment

BY Alaric DeArment

AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.

The market for the drug is $23 million, according to IMS Health.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Exergen granted new patent for TemporalScanner brand of thermometers

BY Allison Cerra

WATERTOWN, Mass. — Exergen said a new patent granted to the company protects its temporal artery thermometers brand.

Exergen said its portfolio of intellectual property rights has expanded with the new patent for its TemporalScanner brand of noninvasive thermometry products. Recently, Exergen said it filed a patent infringement suit in the U.S. District Court for the District of Massachusetts against Kidz-Med, American Scientific Resources and Tecnimed SRL.

"This new patent confirms and protects important innovations in noninvasive thermometry contained in our temporal artery thermometers," said Francesco Pompei, Exergen CEO and inventor of the patented technology. "These innovations are central to the overwhelming success of the temporal artery method, which many competitors would like to use. As a U.S. manufacturer, we rely on strong patent protection to protect our rights, and do our part to help protect the spirit of innovation in a highly competitive world."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?